neuroscience Demise

Quote






Anonymous said:
don't know any exact date, but I heard we will be having some sort of major reshuffle in the fall....
Click to expand...

It will have to happen in time to impact the numbers for fiscal end-of-year. The timing aspects will be geared to ensuring that no major wall street types change their outlook to "sell." Watch for the massive number crunching to start sometime in July, then everything will get hush hush as the tea leaves are being read. Or, in the case of the exodus to China, the "tea leaves will be red."
 






Anonymous said:
Lilly would be best suited to just hire all Contract Sales people anyway. Contract Reps this days or great sales reps that have been displaced by Big Pharma companies because of Mass layoffs or who have been in contract for many years and don't want to deal with the big pharma bullshit. It is the wave of the future and Lilly Sales reps should embrace any contract rep that they come in contact with because we might just save your jobs by moving market with the unbelievable relationships that he have with many doctors. Selling in Pharma this days is not about how good your product is anymore but what kind of personal relationship you have with your doctors. Embrace the Contract Reps Lilly folks because we are here to stay.
Click to expand...


"Contract reps THIS days?


"Who have been IN CONTRACT "?


"Relationships that HE have"?


"Selling in Pharma THIS days"?


Do you even have a college degree? Where did you done git you grammar from?
 












I'm hearing severe cuts to come in the summer as well.. Institution is a ghost town- they've all posted out to other assignments.. Not sure on the status of the office based or PC reps.
 


































































Not sure if that is true...but what is obvious is that we don't need MSK for Cymbalta. The launch of the 2 pain indications has done nothing for the market share nationally. That sales force is full of jokes.
 












Please.. Look at the IMS data Bad all around. MSK portfolio is grim. But come on Neuro pals. Our glory days with top notch products are done. Once Viagara goes generic in 012- bye bye Cialis. Yeah get someone to pay $150/month out of pocket for the daily like the company is pushing... really????? The pipeline isn't too hot and the potential for products to ever make it out of the FDA these days.. Best of luck!!!!
 


















Top Bottom
Back
Quote